2.7.1.81 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25074529&form=6&db=m Genetic association between AGPHD1 variant and lung cancer risk. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 2.7.1.81 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25074529&form=6&db=m Genetic association between AGPHD1 variant and lung cancer risk. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 2.7.1.81 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25854352&form=6&db=m Meta-analysis of the association between the rs8034191 polymorphism in AGPHD1 and lung cancer risk. causal interaction,unassigned 1,0 2.7.1.81 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25999661&form=6&db=m Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population. unassigned - 2.7.1.81 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27072204&form=6&db=m Different effects of the three polymorphisms on 15q25.1 onlung cancer risk: Evidence from published literatures. causal interaction,therapeutic application,unassigned 2,1,0 2.7.1.81 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26634245&form=6&db=m A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. causal interaction,unassigned 3,0